Related Experiment Video
Updated: Jan 17, 2026

Optimized Protocols for Mycobacterium leprae Strain Management: Frozen Stock Preservation and Maintenance in Athymic Nude Mice
Published on: March 23, 2014
Endemicity, disability and neglect: Leprosy in Colombia 2007-2020
Carlos Arango-Úsuga1, Jesús Ochoa1, Doracelly Hincapié-Palacio1
1Universidad de Antioquia - Facultad Nacional de Salud Pública, Medellín, Colombia.
Background:
Disability due to leprosy in Colombia is a neglected public health problem. This work aims to describe the magnitude of leprosy in Colombia, the spatiotemporal distribution of the disability and explore the potential relationship between individual and treatment delay characteristics with degrees of disability.
Methods:
Official leprosy data in Colombia between 2007 and 2020 were analyzed. The distribution of the grade 2 disability (G2D) rate was estimated. A Poisson spatiotemporal model was constructed to form clusters of municipalities with risk of G2D. A multinomial logistic regression model was used to quantify the relationships between patient characteristics and disability grades 1 (G1D) and 2 (G2D).
Results:
During the fourteen-year period, 5240 leprosy cases were registered (median age: 51 years, IQR: 35-63), of which 63.8% (n = 3341) were men. The proportion of multibacillary forms was 65.9% (n = 3453), 47.1% (n = 2468) for grade 0 disability (G0D), 18.4% (n = 966) for G1D and 9.7% (n = 507) for G2D. Three clusters and 10 municipalities were detected for the municipal rate of G2D. The national rate of G2D ranged between 0.03/100,000 inhabitants in 2010 and 0.05/100,000 inhabitants in 2020. The prevalence ratio of G1D and G2D was significant in individuals aged 60 years or older, men, from the subsidized or uninsured health system, who had relapses, multibacillary type and in whom the delay between the onset of symptoms and treatment was 7-12 years.
Conclusion:
In the context of leprosy elimination in Colombia, the prevalence of disability is high and heterogeneous in time and space. It is recommended to coordinate the necessary actions to "revitalize" the active epidemiological surveillance in the prioritized municipalities and strengthen the program including improving early detection, treatment and individual follow-up of patients with disabilities.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

